Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Àü¸³¼±ºñ´ëÁõ°ú Àü¸³¼±¾ÏÀÇ °¨º°Áø´Ü¿¡ À־ Free / Total PSAÀÇ ¿ªÇÒ The Role of Free/Total PSA in the Differential Diagnosis of the Prostate Cancer and Benign Prostatic Hyperplasia

´ëÇѺñ´¢±â°úÇÐȸÁö 1997³â 38±Ç 12È£ p.1311 ~ 1317
È«¹ü½Ä, ¾ÈÇÑÁ¾, ·ùÁø¼÷,
¼Ò¼Ó »ó¼¼Á¤º¸
È«¹ü½Ä (  ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø

¾ÈÇÑÁ¾ (  ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø
·ùÁø¼÷ (  ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø

Abstract

°á·Ð
Àü¸³¼±¾Ï°ú Àü¸³¼±ºñ´ëÁõÀÇ °¨º°Áø´Ü¿¡ À־ ÃÑ PSAÀÇ cut-off value 6.0 ng/§¢°ú ºñ±³
ÇÒ ¶§ free/total PSA cut-off value¸¦ 0.20À¸·Î Çϸé Áø´ÜÀÇ ¹Î°¨µµ´Â 93%·Î À¯ÁöÇϸ鼭 Ư
À̵µ¸¦ 32%¿¡¼­ 52%·Î 20% Çâ»ó½Ãų ¼ö ÀÖ´Ù. ƯÈ÷ ¼ö½ÅÀÚ ÆÇ´Ü°î¼±¿¡¼­ º¸¿©ÁÖµíÀÌ
PSA°¡ 4.0 ng/§¢¿¡¼­ 10.0 ng/§¢»çÀÌÀÇ È¯ÀÚ¿¡ À־ free/total uSA´Â ÃÑ PSA¿¡ ºñÇØ º¸
´Ù ½Å·Úµµ°¡ ³ôÀº °Ë»ç¶ó°í ÆǴܵȴÙ.
#ÃÊ·Ï#
Objectives: This study examined the role of free/total prostate specific antigen (PSA)
in the differentiation between prostate cancer and benign prostatic hyperplasia (BPH) in
patients with total PSA higher than 4.0 ng/§¢
Materials and Methods: Fourteen untreated patients with prostate cancer and 63
patients with BPH were included in this study All patients were pathologically
diagnosed by sextant transrectal biopsy before treatment. The level of total PSA and
free PSA were determined by immunoradiometric assay (Cis bio international). The
median values of total PSA and F/T (free/total PSA) were compared between prostate
cancer and BPH in the three different ranges of total PSA (PSA>4.0 ng/§¢, 4.0 ng/§¢
corves were obtained using sensitivity and specificity of total PSA and F/T at each
cutoff level.
Results: In the range of PSA between 4.0 and 10.0ng/§¢ , the median value of F/T
was significantly different between prostate cancer and BPH (p<0.05), while that of total
PSA was not. In other ranges of PSA, both total PSA and F/T were significantly
different between prostate cancer and BPH. The area under the F/T ROC curve was
significantly larger than that of total PSA ROC coNe only in the range of PSA between
4.0 and 10.0 ng/§¢. In the mean time, F/T was more specific than total PSA (52% vs
32%) at the identical sensitivity (93%) of F/T and total PSA cutoff values (F/T cutoff,
0.2; total PSA cutoff, 6.0 ng/§¢).
Conclusions: Free/Total PSA might provide us more reliable information on the
differential diagnosis of the prostate cancer, especially in patients with PSA range
between 4.0 and 10.0 ng/§¢.

Å°¿öµå

PSA; Free PSA; Benign prostatic hyperplasia; Prostate cancer;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS